Metraipolis › archive › dc_d74ce46be34d

Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer — Europe PMC PMID:41092110

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41092110
DOI
10.1093/carcin/bgaf067
License (as archived)
solo-consultazione
Archived
2026-11-08T21:19:03.423Z
SHA-256 of the archived text
073cb7185e6676939042506335fad07fb652d3838abb562072fc54ba16ee9213
Stable URL of this page
https://metraipolis.com/documento/dc_d74ce46be34d

How to cite

Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer — Europe PMC PMID:41092110 — Europe PMC (en), https://europepmc.org/article/MED/41092110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d74ce46be34d (Metraipolis archive dc_d74ce46be34d, sha256 073cb7185e6676939042506335fad07fb652d3838abb562072fc54ba16ee9213)
BibTeX
@misc{dcd74ce46be34d,
  title = {Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer — Europe PMC PMID:41092110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41092110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d74ce46be34d; sha256 073cb7185e6676939042506335fad07fb652d3838abb562072fc54ba16ee9213},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41092110. Agents can read the archived copy with the MCP tool read_document.